- call +1-201-465-4211
- email sales@mrinsights.biz
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.
Scope of the Report:
This report studies the Molecular Diagnostics in Infectious Disease Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Molecular Diagnostics in Infectious Disease Testing market by product type and applications/end industries.
North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.
Technological advancement in diagnostic procedures for infectious diseases, the increasing prevalence of infectious diseases, a growing elderly population, and the growth of research activities in molecular diagnostic technologies are some major drivers for the global molecular diagnostics in infectious disease testing market.
The global Molecular Diagnostics in Infectious Disease Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Molecular Diagnostics in Infectious Disease Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Qiagen
Genomix Biotech
BioTheranostics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
Academic Institutes
Laboratories
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Molecular Diagnostics in Infectious Disease Testing Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics in Infectious Disease Testing
1.2 Classification of Molecular Diagnostics in Infectious Disease Testing by Types
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Types in 2017
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.5 Microarrays
1.2.6 Next-Generation Sequencing (NGS)
1.2.7 Hybridization
1.2.8 Others
1.3 Global Molecular Diagnostics in Infectious Disease Testing Market by Application
1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic Institutes
1.3.5 Laboratories
1.3.6 Others
1.4 Global Molecular Diagnostics in Infectious Disease Testing Market by Regions
1.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Molecular Diagnostics in Infectious Disease Testing (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 BD
2.2.1 Business Overview
2.2.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BD Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 BioMerieux
2.3.1 Business Overview
2.3.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Thermo Fisher Scientific
2.4.1 Business Overview
2.4.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
2.5.1 Business Overview
2.5.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Siemens
2.6.1 Business Overview
2.6.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Veridex
2.7.1 Business Overview
2.7.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Luminex
2.8.1 Business Overview
2.8.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 GenMark Diagnostics
2.9.1 Business Overview
2.9.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Qiagen
2.10.1 Business Overview
2.10.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 Genomix Biotech
2.11.1 Business Overview
2.11.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.12 BioTheranostics
2.12.1 Business Overview
2.12.2 Molecular Diagnostics in Infectious Disease Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Molecular Diagnostics in Infectious Disease Testing Market Competition, by Players
3.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Molecular Diagnostics in Infectious Disease Testing Players Market Share
3.2.2 Top 10 Molecular Diagnostics in Infectious Disease Testing Players Market Share
3.3 Market Competition Trend
4 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions
4.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Regions
4.2 North America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
4.5 South America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
5 North America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries
5.1 North America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
5.2 USA Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
6 Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Countries
6.1 Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
6.2 Germany Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
6.3 UK Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
6.4 France Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Countries
7.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
7.2 China Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
7.5 India Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
8 South America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries
8.1 South America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
8.2 Brazil Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Molecular Diagnostics in Infectious Disease Testing by Countries
9.1 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2013-2018)
10 Global Molecular Diagnostics in Infectious Disease Testing Market Segment by Type
10.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Type (2018-2023)
10.3 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2013-2023)
10.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Growth Rate (2013-2023)
10.5 Microarrays Revenue Growth Rate (2013-2023)
10.6 Next-Generation Sequencing (NGS) Revenue Growth Rate (2013-2023)
10.7 Hybridization Revenue Growth Rate (2013-2023)
10.8 Others Revenue Growth Rate (2013-2023)
11 Global Molecular Diagnostics in Infectious Disease Testing Market Segment by Application
11.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2013-2018)
11.2 Molecular Diagnostics in Infectious Disease Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Academic Institutes Revenue Growth (2013-2018)
11.6 Laboratories Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast (2018-2023)
12.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast (2018-2023)
12.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Regions (2018-2023)
12.3 North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
12.4 Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
12.6 South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Molecular Diagnostics in Infectious Disease Testing Picture
Table Product Specifications of Molecular Diagnostics in Infectious Disease Testing
Table Global Molecula
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
